Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
HIKAL is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -24.025.3618.42-7.8322.01

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is -24.02 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-24.02
Mar20225.36
Mar202118.42
Mar2020-7.83
Mar201922.01

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42
Positive
Mar2020 -7.83
Negative
Mar2019 22.01 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹3,636.1 Cr -3.8% 3.5% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-3.8%

3.5%

0.3%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses